An Intervention Program to Control Diabetes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00543621 |
Recruitment Status
:
Completed
First Posted
: October 15, 2007
Last Update Posted
: October 15, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetes Mellitus, Type 2 | Other: daily enteral nutritional product and/or behavioral changes | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 150 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | An Intervention Program to Control Diabetes |
Study Start Date : | May 2005 |
- HbA1c, Fasting blood glucose,blood pressure, weight loss [ Time Frame: 24 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Inclusion Criteria:
- informed consent
- 18-70 adults
- Type 2 Diabetes
- Males and non-pregnant females
Exclusion Criteria:
- Use of exogenous insulin for glucose control
- Use of medications or supplements for weight loss
- Advanced diabetes complications
- Recent history of cardiovascular event

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00543621
China | |
Huandong Hospital | |
Shanghai, China |
Principal Investigator: | Jianqin Sun, MD, MPH | Clinical Nutrition Center, Huadong Hospital |
ClinicalTrials.gov Identifier: | NCT00543621 History of Changes |
Other Study ID Numbers: |
Welltech Study |
First Posted: | October 15, 2007 Key Record Dates |
Last Update Posted: | October 15, 2007 |
Last Verified: | October 2007 |
Additional relevant MeSH terms:
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |